Mylan Reports Voluntary EpiPen & EpiPen Jr Recall
Posted on April 2, 2017

Last Friday, the pharmaceutical company Mylan, announced a voluntary recall of specific lots of its products, EpiPen 2-Pak® or EpiPen Jr 2-Pak®.

Information on the recall, affected lot numbers and instructions for those with affected products can be found by clicking here.

If you have any questions, please don't hesitate to contact AASC and speak with one of our clinical staff members.

Return to Recent News